Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.816019
Title: Investigating a combined cell and gene therapy for cystic fibrosis : working towards a proof of principle
Author: Avgerinou, Afroditi
ISNI:       0000 0004 9359 4214
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2020
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Cystic fibrosis (CF) is the most common heritable disease among people with Northern European ancestry. CF is a life-limiting condition affecting multiple systems, however its morbidity and mortality are associated with progressive lung disease followed by respiratory failure. Currently, there is no available cure for CF, as most drugs work only for patients with specific mutations and show limited efficacy. We believe that a combined cell and gene therapy approach (ex vivo gene therapy) where the patient’s own airway cells are corrected by CFTR gene editing in vitro and subsequently transplanted to the lungs, could provide a cure for all patients with CF. Here, we show that we can successfully expand and differentiate primary human airway epithelial cells while maintaining physiological marker expression, electrical responses and CFTR expression. We optimised nucleofections and CRISPR/Cas9 RNP mediated double strand breaks in order to correct the ΔF508 CFTR mutation in patient cells. Correction was achieved through the homology directed repair (HDR) pathway with the help of a donor repair plasmid with a puromycin selection cassette. A second correction approach which included scarless removal of the selection cassette was not successful. We also created an isogenic CFTR knockout in Normal Human Bronchial Epithelial (NHBE) cells, which, after single cell cloning, maintains the ability to form a monolayer and differentiate towards different cell types such as ciliated and mucus cells. Furthermore, we have optimised a protocol for full decellularisation of rat tracheas via a system, which includes perfusion of solutions through the trachea lumen with a pump. CF primary airway epithelial cells engraft in these acellular scaffolds and form a cell layer positive for airway epithelial cell markers. Finally, we have successfully created injury in mouse lungs by intratracheal instillation of polidocanol, which will promote engraftment of delivered airway epithelial cells among the native epithelium.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.816019  DOI: Not available
Share: